The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.55
Bid: 9.30
Ask: 9.80
Change: -0.05 (-0.52%)
Spread: 0.50 (5.376%)
Open: 9.60
High: 9.60
Low: 9.55
Prev. Close: 9.60
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 18th Sep 2018 16:19

Wednesday 19 September 
KingfisherHalf Year Results
Babcock InternationalTrading Statement 
Stagecoach GroupTrading Statement 
RA InternationalHalf Year Results
Yu GroupHalf Year Results
Alliance PharmaHalf Year Results
Cello Health GroupHalf Year Results
Accesso TechnologyHalf Year Results
Greencoat RenewablesHalf Year Results
ErgomedHalf Year Results
QuixantHalf Year Results
EKFHalf Year Results
Thursday 20 September 
IG GroupQ1 Results
Kier GroupHalf Year Results
SOCO InternationalHalf Year Results
Safestyle UKHalf Year Results
City PubHalf Year Results
hVIVOHalf Year Results
LamprellHalf Year Results
Brooks Macdonald GroupFull Year Results
ScisysHalf Year Results
Venture Life GroupHalf Year Results
Inland HomesFull Year Results
Modern WaterHalf Year Results
French ConnectionHalf Year Results
FW ThorpeFull Year Results
Friday 21 September 
Smiths GroupFull Year Results
SIGHalf Year Results
M&C SaatchiHalf Year Results
Triple Point Social HousingHalf Year Results
New Star Investment TrustFull Year Results
Monday 24 September 
Pennon GroupTrading Statement 
Gama AviationHalf Year Results
XLMediaHalf Year Results
KapeHalf Year Results
MaxcyteHalf Year Results
InstemHalf Year Results
Trinity ExplorationHalf Year Results
River & Mercantile GroupFull Year Results
DeltexHalf Year Results
Tuesday 25 Setember 
NextHalf Year Results
AG BarrHalf Year Results
Close BrothersFull Year Results 
OsiriumHalf Year Results
FireAngel SafetyHalf Year Results
Card FactoryHalf Year Results
S&UHalf Year Results
Keystone LawHalf Year Results
Altitude GroupHalf Year Results
Animalcare GroupHalf Year Results
EbiquityHalf Year Results
Menhaden CapitalHalf Year Results
WANdiscoHalf Year Results
Mortgage Advice BureauHalf Year Results
Learning TechnologiesHalf Year Results
Thomas Cook GroupTrading Statement 
United UtilitiesTrading Statement 
Hotel Chocolat GroupFull Year Results 
Harvey Nash GrouipHalf Year Results
Moss BrosHalf Year Results
SSEFinancial Outlook Statement
Blancco Technology GroupFull Year Results 
ScancellFull Year Results 
  

More News
25 Apr 2019 11:19

Scancell gets go-ahead for UK second phase trials of 'SCIB1'

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of 'SCIB1' in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.

Read more
8 Apr 2019 11:34

Scancell Holdings expands IP protection with Japanese patent

(Sharecast News) - Scancell Holdings on Monday won a Japanese patent for its Moditope immunotherapy platform, which stimulates the production of cells that overcome the immune suppression induced by tumours.

Read more
8 Apr 2019 11:27

Scancell Gets Japan Patent Protecting Moditope Immunotherapy Platform

LONDON (Alliance News) - Scancell Holdings PLC on Monday said the Japanese Patent Office has granted a patent providing protection for its Moditope immunotherapy platform.The cancer said T

Read more
20 Mar 2019 13:38

Scancell Holdings Gets Further Patent Protection In US And Europe

LONDON (Alliance News) - Immunotherapy firm Scancell Holdings PLC has received a new patent for its Modi-1 drug candidate in the US, it said on Wednesday.The patent, granted by the US in in

Read more
31 Jan 2019 13:59

Loss Widens As Scancell Continues Moditope Cancer Vaccine Development

LONDON (Alliance News) - Scancell Holdings PLC on Thursday said its loss widened in the first half of its year on mounting administrative expenses as its development of Moditope in Scancell were a

Read more
31 Jan 2019 09:48

Scancell shares slip as losses widen in first half

(Sharecast News) - Cancer immunotherapies developer Scancell Holdings issued its interim results for the six months ended 31 October on Thursday, reporting a loss of £3.24m, widening from £2.02m year-on-year.

Read more
23 Jan 2019 11:20

Scancell loses out on Cancer Research UK grant

(Sharecast News) - Immunotherapies developer Scancell has seen Cancer Research UK pass on its submission into the Grand Challenge research initiative.

Read more
23 Jan 2019 10:41

WINNERS & LOSERS SUMMARY: Metro Bank Slumps 29% On Annual Profit Miss

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 1.9%. The airline was extending gains a

Read more
23 Jan 2019 10:18

Scancell Cancer Vaccine Project Misses Out On Cancer Research UK Grant

LONDON (Alliance News) - Scancell Holdings PLC said Wednesday its Project Blueprint proposal was not selected for the Cancer Research UK Grand Challenge grant.Shares in Scancell were down -

Read more
21 Jan 2019 12:58

Scancell Appoints New Head Of Research And Manufacturing Divisions

LONDON (Alliance News) - Scancell Holdings PLC on Monday said it appointed two new executives as head of research and head of manufacturing.Samantha Paston joined Scancell as head of in She

Read more
21 Jan 2019 12:30

Scancell appoints new heads of research and manufacturing

(Sharecast News) - Immunotherapy developer Scancell Holdings announced the appointment of Dr Samantha Paston as its head of research, and Dr Adrian Parry as its head of manufacturing, on Monday.

Read more
30 Oct 2018 16:33

Scancell Holdings Reports Tumour Rejection Data In Cancer Vaccine

LONDON (Alliance News) - Scancell Holdings PLC said Tuesday that data from its second vaccine from its Moditope platform, Modi-2, showed T-cell response, tumour rejection and increased survival in

Read more
30 Oct 2018 14:36

Scancell pleased with progress on 'Moditope' vaccines

(Sharecast News) - Novel immunotherapies developer Scancell Holdings updated the market on the development of its second vaccine from its proprietary 'Moditope' platform, Modi-2, on Tuesday, reporting that pre-clinical data demonstrated that homocitrullinated peptides induced highly potent T-cell responses, tumour rejection and increased survival in murine models.

Read more
24 Oct 2018 12:28

Oxford Technology VCTs Mostly Report Drop In Net Asset Value

LONDON (Alliance News) - The Oxford Technology-managed venture capital trusts reported interim results on Wednesday, with all but one see a drop in net asset value.Oxford Technology Venture

Read more
24 Oct 2018 10:43

WINNERS & LOSERS SUMMARY: Metro Bank Down Amid Mortgage Competition

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 0.9%. The bank reported a rise in third by

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.